摘要
近来研究表明,他汀类药物能有效改善冠心病患者的预后,该效应除与他汀类调脂作用有关外,还和其非调脂作用密切相关。阿托伐他汀是目前国内最新一代他汀类药物。本文综合国内外最新报道,全面阐述了阿托伐他汀非调脂效应在冠心病防治中的作用地位及安全性。
Recent reports have indicated that Statins could remarkably improve the prognosis of patients suffered from coronary artery disease. And this effect is not only due to Statin' s lipid-regulating function, but also correlated to its non-lipid-regulating action. Atorvastatin is the latest kind of statins. In this article, we specified thenon-lipid-regulating effect of Atorvastatin in the prevention and therapy to coronary artery disease. Furthermore, we summarized its corresponding clinical evaluation or security.
出处
《中国临床药理学与治疗学》
CAS
CSCD
2006年第2期141-144,共4页
Chinese Journal of Clinical Pharmacology and Therapeutics
关键词
阿托伐他汀
非调脂作用
冠心病
炎症
安全性
Atorvastatin
non-lipid-regulating effect
coronary artery disease
inflammation
security